Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Pharma Mar SA ( (ES:PHM) ) has issued an update.
Pharma Mar, S.A. has announced the convening of its Ordinary General Meeting of Shareholders, scheduled for June 18, 2025. Key agenda items include the approval of the Annual Accounts, Management Reports, and a proposal for a dividend distribution. The meeting will also address the re-election of a director, authorization for share acquisitions, and a new share delivery plan for employees, reflecting the company’s strategic focus on governance and stakeholder engagement.
More about Pharma Mar SA
Pharma Mar, S.A. operates in the pharmaceutical industry, focusing on the development and commercialization of marine-derived drugs. It is known for its innovative approach in oncology and other therapeutic areas, aiming to address unmet medical needs.
YTD Price Performance: 11.88%
Average Trading Volume: 1,304
Technical Sentiment Signal: Strong Sell
Current Market Cap: $1.56B
For an in-depth examination of PHM stock, go to TipRanks’ Stock Analysis page.